Wednesday November 20, 2019

50 Lakh get Treatment Benefit under Ayushman Bharat Pradhan Mantri Jan Arogya Yojana

According to the National Health Authority (NHA) figures, more than 60 per cent of the amount spent has been on tertiary care

0
//
Treatment, Ayushman Bhaarat, Pradhan Mantri
Under the flagship health assurance scheme of the Narendra Modi government, free secondary and tertiary treatment worth Rs 7,901 crore has been availed in the 32 states and UTs implementing the scheme. Pixabay

Achieving another milestone in just over a year, the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (PM-JAY) on Monday crossed the 50 lakh treatment mark.

There are nine hospital admissions every minute across India under the scheme. Under the flagship health assurance scheme of the Narendra Modi government, free secondary and tertiary treatment worth Rs 7,901 crore has been availed in the 32 states and UTs implementing the scheme.

According to the National Health Authority (NHA) figures, more than 60 per cent of the amount spent has been on tertiary care. Segments like cardiology, orthopaedics, radiation, oncology, cardio-thoracic and vascular surgery, and urology have emerged as the top tertiary specialities.

Gujarat, Tamil Nadu, Chhattisgarh, Kerala and Andhra Pradesh have emerged as the top performing states under the scheme.

Treatment, Ayushman Bhaarat, Pradhan Mantri
Under the flagship health assurance scheme of the Narendra Modi government, free secondary and tertiary treatment worth Rs 7,901 crore has been availed in the 32 states and UTs implementing the scheme. Pixabay

Union Health Minister Harsh Vardhan said: “The Ayushman Bharat family is growing by leaps and bounds. In just over one year, under PM-JAY more than 50 lakh treatments have been availed by beneficiaries across the country.”

NHA CEO Indu Bhushan said: “50 lakh hospital treatments is a significant milestone for PM-JAY, but there is a long journey ahead. The scheme will continue to focus on reducing catastrophic out-of-pocket health expenditure, improving access to quality health care and meeting the unmet need of the population for hospitalization care, so that we move towards the vision of Universal Health Coverage.”

The 50 lakh hospital admissions have taken place in the public and empanelled private hospitals that provide care to the beneficiaries under the scheme. To date, 18,486 hospitals have been empanelled across India. In the first year, 53 per cent of the empanelled hospitals are private, especially multi-specialty hospitals. There have been more than 50,000 portability cases, wherein migrant and travelling eligible Indians have availed their treatment outside their home states.

Also Read- Abhijit Banerjee: All you Need to Know about Nobel Laureate

The aim of PM-JAY is to bring quality healthcare to more than 50 crore poor and vulnerable Indians across the country. The scheme gives annual healthcare benefits of up to Rs 5 lakh for every entitled family, and provides cashless and paperless access to services for the beneficiary at the point of service. (IANS)

Next Story

A Molecule in Immune System Can Target and Kill Cancer Cells: Study

Crucially, there is a need to induce the immune system to ensure long-term protection against the recurrence of cancer

0
Immune
Current approaches to achieve this involve killing Cancer cells by using chemotherapeutics and other agents which could be harmful and have uncertain outcomes other than Immune Bacteria. Pixabay

Researchers have found a naturally occurring molecule and a component of the Immune system that could successfully target and kill Cancer cells, according to a study.

The study, published in British Journal of Cancer, discovered that beta-galactoside-binding protein, a naturally occurring molecule produced by immune cells can non-specifically target cancer cells, make them undergo cell death and through a stress response pathway make the cancer cells visible to the immune system to prompt an anti-cancer immune response that would secure protection against recurrences.

“By contrast, the anti-tumour property of the molecule is selective and not harmful to normal cells. It is effective against the most aggressive colorectal cancer cells and a wide range of other cancer cells equally unresponsive to current therapies,” said study lead author Professor Livio Mallucci from King’s College London.

“This research presents experimental evidence for a strategy where the targeting of cancer cells and the stimulation of immunity combine to prompt immediate and long-term responses against aggressive cancer,” he said.

According to the researchers, major developments in anti-cancer therapies have taken place over the last decade, but as only a subset of patients respond to treatments, there is a need for further development.

Crucially, there is a need to induce the immune system to ensure long-term protection against the recurrence of cancer.

Immune
Researchers have found a naturally occurring molecule and a component of the Immune system that could successfully target and kill Cancer cells, according to a study. Pixabay

Current approaches to achieve this involve killing cells by using chemotherapeutics and other agents which could be harmful and have uncertain outcomes, the study said.

ALSO READ: WHO Demands Strict Regulations on Vaping Products

“Translation of the molecule to the clinic could open a new therapeutic opportunity which safely combines direct killing of cancer cells and the stimulation of the immune system against recurrences, a significant step forward in the management of cancer,” he added. (IANS)